<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04398654</url>
  </required_header>
  <id_info>
    <org_study_id>PASSPORT-HF</org_study_id>
    <nct_id>NCT04398654</nct_id>
  </id_info>
  <brief_title>Pulmonary Artery Sensor System Pressure Monitoring to Improve Heart Failure (HF) Outcomes</brief_title>
  <official_title>Pulmonary Artery Sensor System Pressure Monitoring to Improve Heart Failure (HF) Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IHF GmbH - Institut für Herzinfarktforschung</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IHF GmbH - Institut für Herzinfarktforschung</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized, parallel group controlled study examines the effect of supporting the Heart&#xD;
      failure supply through pulmonary arterial (PA) pressure measurement with the CardioMEMS™ HF&#xD;
      system to hard endpoints, safety and quality of life. The target population consists of heart&#xD;
      failure (HF) patients who have been predominantly in New York Heart Association (NYHA) Stage&#xD;
      III for the past 30 days and at least once in the past 12 months for HF were admitted to&#xD;
      hospital. All patients receive basic care, which is based on structured telephone contact&#xD;
      (between the care center, patient and family doctor) to optimize guideline compliant therapy.&#xD;
      In the intervention group a PA pressure sensor is (CardioMEMS™-HF Sensor) implanted. These&#xD;
      patients are structured by specially trained non-medical personnel aftercare with additional&#xD;
      inclusion of the PA pressure values: adjusted to the basis of the information collected in PA&#xD;
      monitoring the therapy is optimized. The follow-up period until the primary endpoint is 12&#xD;
      months.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 2, 2020</start_date>
  <completion_date type="Anticipated">May 30, 2024</completion_date>
  <primary_completion_date type="Anticipated">May 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary efficacy endpoint: composite of unplanned HF-related rehospitalisations and all-cause death</measure>
    <time_frame>12 months</time_frame>
    <description>Composite endpoint of number of unplanned HF-related rehospitalisations or all-cause death</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Primary safety endpoint: device-related complications</measure>
    <time_frame>12 months</time_frame>
    <description>Rate of Device / System related complications</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Co-primary safety endpoint: sensor failure</measure>
    <time_frame>12 months</time_frame>
    <description>Rate of sensor failures</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major secondary endpoint: changes in disease-related quality of life</measure>
    <time_frame>6 and 12 months</time_frame>
    <description>Change in quality of life score after 6 and 12 month measured by Kansas City Cardiomyopathy questionnaire. Scores are transformed to a range of 0-100, in which higher scores reflect better health status.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in generic health-related quality of life</measure>
    <time_frame>6 and 12 months</time_frame>
    <description>Change in Quality of Life score after 6 and 12 month measures by EQ-5D questionnaire.&#xD;
The EQ-5D-5L descriptive system comprises the five dimensions (MOBILITY, SELF-CARE, USUAL ACTIVITIES, PAIN / DISCOMFORT and ANXIETY / DEPRESSION), each dimension has five response levels:&#xD;
no problems, slight problems, moderate problems, severe problems, unable to /extreme problems. Responses are coded as single-digit numbers expressing the severity level selected in each dimension (1 - 5, where higher scores indicate more severe problems).&#xD;
The EQ VAS records the respondent's overall current health on a vertical visual analogue scale (0-100), where the endpoints are labelled 'The best health you can imagine - 100' and 'The worst health you can imagine - 0'. The EQ VAS provides a quantitative measure of the patient's perception of their overall health.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HF-related mortality</measure>
    <time_frame>12 months</time_frame>
    <description>Rate of HF-related mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular Mortality</measure>
    <time_frame>12 months</time_frame>
    <description>Rate of cardiovascular mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause Mortality</measure>
    <time_frame>12 months</time_frame>
    <description>Rate of all-cause mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unplanned HF-related hospitalizations</measure>
    <time_frame>12 months</time_frame>
    <description>Rate of HF-related hospitalisations</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unplanned cardiovascular-related hospitalizations</measure>
    <time_frame>12 months</time_frame>
    <description>Rate of cardiovascular-related hospitalisations</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unplanned all-cause hospitalizations</measure>
    <time_frame>12 months</time_frame>
    <description>Rate of all-cause hospitalisations</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unplanned hospitalizations, other</measure>
    <time_frame>12 months</time_frame>
    <description>Number of days alive and out of hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non-serious Adverse Events</measure>
    <time_frame>12 months</time_frame>
    <description>Rate of non-serious adverse events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serious Adverse Events</measure>
    <time_frame>12 months</time_frame>
    <description>Rate of serious adverse events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symptoms of heart failure</measure>
    <time_frame>12 months</time_frame>
    <description>Patient-reported symptoms of heart failure, measured by of the KCCQ Symptoms Score</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">554</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Monitoring and therapy adjustment within the scope of the basic care described in the clinical trial plan.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>As in control group. In addition, in the intervention arm the CardioMEMSTM HF sensor implanted.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CardioMEMSTM HF sensor - pulmonary artery pressure measurement</intervention_name>
    <description>CardioMEMSTM HF sensor implantation to meassure pulmonary artery pressure. Evaluation of the pressure curves by telemetric transmission and coordination of necessary adjustments of the therapy.</description>
    <arm_group_label>Intervention Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Written consent received from the patient or a legal representative after the&#xD;
             in-formation has been provided.&#xD;
&#xD;
          2. ≥≥ 18 years of age.&#xD;
&#xD;
          3. Predominant symptoms in NYHA Stage III in the 30-day period prior to consent to the&#xD;
             study.&#xD;
&#xD;
          4. Objectified HF diagnosis for more than three months.&#xD;
&#xD;
          5. Hospitalisation within 12 months prior to inclusion due to deterioration of HF&#xD;
             symptoms.&#xD;
&#xD;
          6. Able to tolerate dual antiplatelet therapy or anticoagulation therapy for one month&#xD;
             after sensor implantation&#xD;
&#xD;
          7. Patients with reduced left ventricular ejection fraction (LVEF) ≤40% (diagnosed within&#xD;
             6 months prior to inclusion) must be treated with guideline-compliant HF&#xD;
             pharmacotherapy; if one class of guideline-compliant medication is not tolerated,&#xD;
             appropriate documentation must be supplied; patients must receive and tolerate at&#xD;
             least one class of guideline-compliant medication; if no guideline-compliant&#xD;
             medication is tolerated at all, the patient may not participate in the study.&#xD;
&#xD;
          8. In patients with preserved LVEF (&gt;40%; diagnosed within 6 months prior to inclu-sion)&#xD;
             comorbidities must be treated in accordance with guideline-compliant medi-cation.&#xD;
&#xD;
          9. Chest circumference (measured at axillary level) of less than 165 cm if BMI &gt;35 kg/m2.&#xD;
&#xD;
         10. Willing and mentally and physically able to meet the requirements for follow-up and&#xD;
             long-term basic care (this includes the long-term willingness of the patient, and of&#xD;
             their relatives where relevant, to participate in PA pressure-based monitor-ing).&#xD;
&#xD;
         11. Appropriate domestic situation, defined as being accessible by telephone (via fixed or&#xD;
             mobile network) .&#xD;
&#xD;
         12. For the intervention group: Implantation is only performed if the diameter of the&#xD;
             pulmonary artery branch intended for implantation is ≥7 mm (assessment will be made&#xD;
             during the right heart catheterization)&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          1. Enrolment in another study with an active treatment arm.&#xD;
&#xD;
          2. Severe cardiovascular event (e.g. myocardial infarction, open heart surgery, stroke,&#xD;
             CRT implantation) in the 2 months prior to admission&#xD;
&#xD;
          3. Therapy-refractory heart failure in ACC/AHA stage D or new therapies that have taken&#xD;
             place or are planned in the next 12 months (e.g. implantation of a left ven-tricular&#xD;
             assist system / transplantation)&#xD;
&#xD;
          4. Active infection.&#xD;
&#xD;
          5. History of recurrent (&gt;1 episode) pulmonary embolism and/or deep vein throm-bosis.&#xD;
&#xD;
          6. Continuous or intermittent chronic inotropic therapy.&#xD;
&#xD;
          7. Estimated glomerular filtration rate (eGFR) &lt;25 ml/min&#xD;
&#xD;
          8. Life expectancy (according to the study physician's assessment) &lt;12 months.&#xD;
&#xD;
          9. Severe, unrepaired congenital heart defect that would prevent implantation of the&#xD;
             sensor.&#xD;
&#xD;
         10. Severe valve vitium with planned intervention in the next 3 months&#xD;
&#xD;
         11. Presence of a mechanical right heart valve.&#xD;
&#xD;
         12. Mental disorder that presumably (in the opinion of the study physician) has a negative&#xD;
             impact on patient compliance or consent.&#xD;
&#xD;
         13. Failure of the coordinating physician to approve if the patient is enrolled in an HF&#xD;
             disease management program or comparable case management program.&#xD;
&#xD;
         14. Women of childbearing age with a positive pregnancy test at the time of inclusion&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefan Störk, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wuerzburg University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stefan Störk, MD</last_name>
    <phone>093120146361</phone>
    <email>Stoerk_S@ukw.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Fathema Hassinger, PhD</last_name>
    <email>hassinger@ihf.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>SLK-Kliniken GmbH - Klinikum am Plattenwald</name>
      <address>
        <city>Bad Friedrichshall</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Dengler, Prof Dr med</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kerckhoff-Klinik Forschungs GmbH</name>
      <address>
        <city>Bad Nauheim</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andreas Rieth, Dr med</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Herz- und Diabeteszentrum NRW</name>
      <address>
        <city>Bad Oeynhausen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hendrik Fox, Dr med</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>BG Unfallkrankenhaus Berlin</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sebastian Winkler, Dr med</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Charité Universitätsmedizin (Campus Mitte, Campus Benjamin Franklin)</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Leistner, Prof Dr med</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Deutsches Herzzentrum Berlin</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Felix Schönrath, Dr med</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Praxis am Spreebogen</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Florian Krackhardt, Dr med</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sana Klinikum Lichtenberg</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olaf Göing, Prof Dr med</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Bielefeld</name>
      <address>
        <city>Bielefeld</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christoph Stellbrink, Prof Dr med</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Bonn</name>
      <address>
        <city>Bonn</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ulrich Becher, Dr med</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Coburg</name>
      <address>
        <city>Coburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Steffen Schnupp, Dr med</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>St Johannes Hospital Dortmund</name>
      <address>
        <city>Dortmund</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Helge Möllmann, Prof Dr med</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Praxisklinik Herz und Gefäße</name>
      <address>
        <city>Dresden</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan Spitzer, Prof Dr med</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Georg Klinikum</name>
      <address>
        <city>Eisenach</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcus Jahnecke, Dr med</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Helios Klinikum Erfurt</name>
      <address>
        <city>Erfurt</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander Lauten, Prof Dr med</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Elisabeth Krankenhaus, Contilia Herz- und Gefäßzentrum</name>
      <address>
        <city>Essen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oliver Bruder, Dr med</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Essen</name>
      <address>
        <city>Essen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Peter Lüdike, Dr med</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Frankfurt</name>
      <address>
        <city>Frankfurt</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mariuca Vasa-Nicotera, Dr med</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Gießen</name>
      <address>
        <city>Gießen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Birgit Aßmus, Prof Dr med</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitäres Herz- und Gefäßzentrum Hamburg</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Christina Magnussen, Dr med</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover</name>
      <address>
        <city>Hannover</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tibor Kempf, Prof Dr med</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Westpfalz Klinikum</name>
      <address>
        <city>Kaiserslautern</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Burghard Schuhmacher, Prof Dr med</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Karlsburg</name>
      <address>
        <city>Karlsburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Basil Alkhlout, Dr med</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Vinzenz Hospital</name>
      <address>
        <city>Köln</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan Winter, Dr med</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Leipzig Heart Institute GmbH</name>
      <address>
        <city>Leipzig</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gerhard Hindricks, Prof Dr med</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Oldenburg</name>
      <address>
        <city>Oldenburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lea Seidlmayer, Dr med</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Vest</name>
      <address>
        <city>Recklinghausen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank Weidemann, Prof Dr med</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cardio Consil Rostock</name>
      <address>
        <city>Rostock</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jens Placke, Dr med</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Krankenhaus der Barmherzigen Brüder</name>
      <address>
        <city>Trier</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neriman Osman, Dr med</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Schwarzwald-Baar Klinikum</name>
      <address>
        <city>Villingen-Schwenningen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Werner Jung, Prof Dr med</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rems-Murr Klinikum</name>
      <address>
        <city>Winnenden</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michael Sailer, Dr med</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Deutsches Zentrum für Herzinsuffizienz (DZHI)</name>
      <address>
        <city>Würzburg</city>
        <zip>97080</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan Störk, Prof Dr med</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 13, 2020</study_first_submitted>
  <study_first_submitted_qc>May 18, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 21, 2020</study_first_posted>
  <last_update_submitted>May 11, 2021</last_update_submitted>
  <last_update_submitted_qc>May 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

